Related Experiment Video
Updated: Oct 6, 2025

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
A smartphone application for remote adjustment of warfarin dose: Development and usability study
Shaojun Jiang1, Meina Lv1, Tingting Wu1
1Fujian Medical University Union Hospital, No.29 Xinquan Road, Fuzhou 350001, Fujian, China.
This study introduces a smartphone application designed to help patients manage their blood-thinning medication remotely. By allowing users to adjust dosages without frequent hospital visits, the tool aims to save time and reduce costs. Researchers tested the system with both patients and medical staff to see how easy it was to use. While medical professionals found the interface highly functional, patients reported that the experience could be improved. Overall, the platform successfully facilitated thousands of remote adjustments, showing promise for future home-based care.
Area of Science:
- Digital health interventions within warfarin management research
- Health informatics and mobile application development
Background:
Chronic medication management often requires frequent clinical visits that impose significant burdens on patients. This necessity for regular monitoring creates a substantial gap in efficient, patient-centered care delivery. Prior research has shown that traditional in-person protocols consume considerable time and financial resources. That uncertainty drove the exploration of digital alternatives to streamline therapeutic adjustments. No prior work had resolved how to balance safety with the convenience of remote platforms for anticoagulation therapy. This gap motivated the creation of a dedicated mobile interface for managing complex drug regimens. Digital tools offer potential solutions for reducing the logistical strain associated with standard outpatient monitoring. The current landscape lacks robust, user-validated systems that bridge the divide between clinical oversight and home-based patient autonomy.
Purpose Of The Study:
The aim of this article is to design and develop a mobile platform for remote medication dose adjustments. Researchers sought to address the logistical challenges faced by patients requiring frequent hospital visits. The project focuses on creating a secure, effective digital environment for managing complex drug administration. By shifting these tasks to a virtual space, the team hopes to reduce the time and financial burden on patients. The study evaluates the usability of the new interface from the perspective of both patients and medical staff. This investigation seeks to determine if digital tools can reliably replace traditional in-person clinical oversight. The authors explore whether such systems can maintain high standards of safety while improving overall convenience. This work provides a necessary assessment of how mobile technology integrates into existing therapeutic workflows.
Main Methods:
Review Approach involved designing a mobile software platform to enable remote therapeutic adjustments for patients. The developers focused on ensuring safety and clinical effectiveness throughout the creation process. Investigators invited a cohort of patients and healthcare providers to participate in a formal evaluation. The team employed the System Usability Scale to quantify the user experience for both groups. Researchers collected data from 26 participants to assess the interface functionality. The study tracked the total number of registered accounts and the volume of remote adjustments performed. Statistical analysis compared usability scores between different age demographics to identify potential barriers. This systematic assessment provided a clear view of how different users interact with the digital tool.
Main Results:
Key Findings From the Literature indicate that the medical terminal achieved a high usability score of 82.7 among healthcare practitioners. The patient terminal received a lower score of 61.8 from the participating cohort. By July 2021, the platform supported 1736 accounts and facilitated 12,968 remote adjustments. Analysis shows that age does not impact the usability of the patient interface. Younger users provided a score of 63.5, while older adults rated the system at 58.5. The difference between these age groups was not statistically significant, with a P-value of .535. Results demonstrate that the medical interface is currently acceptable for clinical use. The data confirm that the system is capable of handling high-frequency remote management tasks.
Conclusions:
Synthesis and Implications suggest that the mobile platform provides a viable pathway for managing anticoagulation therapy from a distance. The authors indicate that medical staff perceive the professional interface as highly functional for their daily tasks. Findings reveal that the patient-facing side requires additional design refinements to better meet user needs. Data indicate that age does not serve as a barrier to navigating the current patient interface. The researchers propose that the system successfully handles high volumes of remote adjustments across a large user base. Evidence confirms that the application effectively supports the transition toward decentralized medication oversight. The team highlights that while the current version is functional, future iterations should prioritize improving the patient experience. These results provide a foundation for integrating mobile health technology into standard clinical workflows for long-term therapy.
Frequently Asked Questions
The researchers propose that the application facilitates remote dosage modifications by connecting patients and clinicians through a digital interface. This mechanism replaces the requirement for in-person hospital visits, which previously served as the primary method for adjusting blood-thinning medication levels.
The team utilized the System Usability Scale (SUS) to evaluate the interface. This standardized questionnaire allowed both patients and medical staff to provide quantitative feedback, resulting in scores of 61.8 for the patient terminal and 82.7 for the medical terminal.
The authors state that the medical terminal is acceptable to practitioners, whereas the patient terminal requires further improvement. This distinction is based on the SUS scores, where professionals rated the system significantly higher than the patients did.
The researchers tracked 1736 total accounts, comprising 1624 patients and 112 medical staff. This data set provided the foundation for analyzing the system's capacity, which supported 12,968 remote adjustments by July 2021.
The study measured usability across different age groups, finding no significant difference in how younger and older adults rated the patient terminal. The scores were 63.5 for younger users and 58.5 for older users, with a P-value of .535.
The researchers propose that this platform can be used for remote management of medication. They conclude that while the current system is functional, future development must focus on enhancing the patient-side experience to ensure broader adoption.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Dosage Regimens: Designs and Approaches
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Dosage Regimen: Individualization
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Drug Dosing: Geriatric Patients

